Aligos Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Aligos Therapeutics, Inc. reported Common Stock Shares Outstanding of 6.18 million shares for the year ending 2025.

  • Aligos Therapeutics, Inc. showed an increase of +59.9% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Aligos Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2019 to 2025), Aligos Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 57.3%.
  • Historical annual values: Fiscal year 2025: 6.18 million shares | Fiscal year 2024: 3.86 million shares | Fiscal year 2024: 79.90 million shares | Fiscal year 2023: 3.00 million shares | Fiscal year 2022: 42.92 million shares | Fiscal year 2021: 42.69 million shares | Fiscal year 2020: 38.12 million shares | Fiscal year 2019: 3.93 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: